BROOKS LAB LIMITED

{
    "company_profile": "Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company\u2019s segment is Pharmaceutical products, including ingredients and intermediaries. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup, and eye/ear drops. Its products under the Carbapenem category are Imipenem 250 (Milligram) mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, and Doripenem 500mg. It offers Penicillins in the form of injections, tablets, and dry syrup. Its general category of products includes liquid injections, dry powder injections and eye/ear drops. Its liquid injections include Iron sucrose 100mg/5ml, Iron sucrose 50mg/2.5ml, Phenytoin sodium 50mg/ml and others. Its dry powder injections include Artesunate 60mg, Artesunate 120mg, Omeprazole 40mg, Rabeprazole 20mg, Pantoprazole 40mg and others. ",
    "sector": "Pharmaceuticals",
    "sector_market_cap_inr": {
        "value": 173.3,
        "unit": "crore",
        "formatted": "173.30 Cr"
    },
    "sector_market_cap_usd": {
        "value": 19.26,
        "unit": "million",
        "formatted": "$19.26M"
    }
}